Galmed Pharmaceuticals Ltd. (GLMD)
$4.05-6.03%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $31M
- Avg volume
- 77.0K
- Beta
- 0.74
- P/E (TTM)
- -0.25
- Short % float
- 1.94%
- Days to cover
- 1.0
- SI change
- +386.5%
- 1W
- -1.46%
- 1M
- -1.22%
- 3M
- -12.72%
- YTD
- -38.45%
- vs SPY 1W
- -0.27%
- vs SPY 1M
- -4.54%
- vs SPY 3M
- -15.11%
- vs SPY YTD
- -50.20%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- GYREBUYGyre Therapeutics, Inc.RECOVERYQ -2$6.44-6.80%
- MNDRSELLMobile-health Network Solutions Class A Ordinary SharesCRISISQ -29$1.65-1.20%
- MDCXSELLMedicus Pharma Ltd. Common StockCRISISQ -35$0.26-3.70%
- NEOBUYNeoGenomics, Inc.BULLQ 25$16.41-3.36%
- OMDABUYOmada HealthBULLQ 6$24.08+0.80%
- PBMBUYPsyence Biomedical Ltd.RECOVERYQ -30$4.22-2.54%
- HOOKSELLHOOKIPA Pharma Inc.BULLQ -18$1.15+0.00%
- TARSBUYTarsus Pharmaceuticals, Inc.RECOVERYQ 24$72.81+0.15%
- NVAXBUYNovavax, Inc.RECOVERYQ 9$8.86-0.89%
- LUNGBUYPulmonx CorporationRECOVERYQ -24$2.28+0.88%
- PTIXBUYProtagenic Therapeutics, Inc.RECOVERYQ -15$1.09+36.25%
- KURABUYKura Oncology, Inc.RECOVERYQ 13$12.40+4.29%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 14
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-38.5%
REV YoY-
ROE-64.1%
EPS YoY-
ROA-69.4%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.25
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.24
P/FCF-
EV/EBITDA-0.23
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO7.71
ND/EBITDA-
BETA0.74
